¿QUÉ AGENTE DE INDUCCIÓN TIENE MEJOR SUPERVIVENCIA DÍA 7 PARA PACIENTES CRÍTICOS QUE REQUIEREN INTUBACIÓN ENDOTRAQUEAL DE URGENCIA, KETAMINA O ETOMIDATO?

 PREGUNTA CLÍNICA: ¿QUÉ AGENTE DE INDUCCIÓN TIENE MEJOR SUPERVIVENCIA DÍA 7 PARA PACIENTES CRÍTICOS QUE REQUIEREN INTUBACIÓN ENDOTRAQUEAL DE URGENCIA, KETAMINA O ETOMIDATO?

Referencia: Matchett, G. et al. Etomidato versus ketamina para la intubación endotraqueal de emergencia: un ensayo clínico aleatorizado. Medicina de cuidados intensivos 2021

Población: Adultos de 18 años de edad y mayores que necesitan intubación endotraqueal (ET) de emergencia

Exclusiones: niños, pacientes embarazadas, pacientes que necesitan intubación ET sin sedación o alérgicos a uno de los agentes que se utilizan

Intervención: Ketamina 1-2mg/kg IV

Comparación: etomidato 0,2-0,3 mg/kg IV

Salir:

Resultado primario: supervivencia de 7 días

Resultados secundarios: supervivencia a los 28 días, duración de la ventilación mecánica, duración de la estancia en la UCI, necesidad de uso de vasopresores, puntajes SOFA y una evaluación de un nuevo diagnóstico de insuficiencia suprarrenal por parte de los equipos de cuidados intensivos tratantes.

Ensayo: Ensayo prospectivo, aleatorizado, de asignación paralela, abierto, de un solo centro (NCT02643381)

Conclusiones de los autores: si bien el resultado primario de supervivencia el día 7 fue mayor en los pacientes asignados al azar a la ketamina, no hubo una diferencia significativa en la supervivencia el día 28".

#víaaérea #paramedicina #medicinadeemergencia #anastesia

https://clinicaltrials.gov/ct2/show/NCT02643381

https://www.anesthesiologynews.com/Airway-Management/Article/12-21/Ketamine-Improves-1-Week-Survival-After-Emergency-Intubation/65376

CLINICAL QUESTION: WHICH INDUCTION AGENT HAS A BETTER DAY 7 SURVIVAL FOR CRITICALLY ILL PATIENTS REQUIRING EMERGENCY ENDOTRACHEAL INTUBATION, KETAMINE OR ETOMIDATE?

Reference: Matchett, G. et al. Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial. Intensive Care Med 2021

Population: Adults 18 years of age and older in need of emergency endotracheal (ET) intubation

Exclusions: Children, pregnant patients, patients needing ET intubation without sedation or allergic to one of the agents being used

Intervention: Ketamine 1-2mg/kg IV

Comparison: Etomidate 0.2-0.3mg/kg IV

Outcome:

Primary Outcome: 7-day survival

Secondary Outcomes: 28-day survival, duration of mechanical ventilation, ICU length of stay, need for vasopressor use, SOFA scores and an assessment of a new diagnosis of adrenal insufficiency by the treating critical care teams.

Trial: Prospective, randomized, parallel-assignment, open-label, single-center trial (NCT02643381)

Authors’ Conclusions: While the primary outcome of Day 7 survival was greater in patients randomized to ketamine, there was no significant difference in survival by Day 28.”

#airway #paramedicine #emergencymedicine #anasthesia

Rob J. Bryant, MD
Emergency Medicine Faculty
Utah Emergency Physicians
Twitter: @RobJBryant13

 Objectives

1. Review current evidence in the use of Etomidate or Ketamine in patients with hemodynamic compromise requiring intubation
2. Be able to defend your choice of Etomidate or Ketamine in patients requiring RSI

Outline

1. Review RSI approaches using standard, and reduced dose Ketamine and Etomidate
2. Review NEAR registry data on recent ED use of these agents
3. Discuss limitations of observational studies

Ketamine vs Etomidate for RSI

• Mohr et al. Acad Emerg Med 2020. PMID: 32602974
  • NEAR Cohort Registry Study
  • Ketamine vs Etomidate in sepsis
  • ≈500 patients: ≈250 etomidate vs ≈140 ketamine
  • Primary Outcome: SBP <100mmHg within 15min of intubation
    • Ketamine = 74% vs Etomidate 50%
  • Vasopressor use within 15min of intubation
    • Ketamine = 30% vs Etomidate = 23%
  • Registry studies at best can show us trends and should be used as hypothesis generating trials and nothing more
  • Without controlling for why a particular agent was used it is impossible to say if one agent was used in a sicker cohort compared to the other (Why was ketamine used instead of etomidate or vice versa?)
  • Study doesn’t answer the question of reduced dose induction agents
• Critical Care 2015. PMID: 25879683
  • Physiologically unstable trauma patients
  • Etomidate 0.15mg/kg + 1.5mg/kg succinylcholine + 1mg/kg rocuronium vs Fentanyl 1mcg/kg + 1mg/kg ketamine + 1mg/kg rocuronium
  • No difference in post intubation hypotension
• April et al. Acad Emerg Med 2020. PMID: 32592205
  • NEAR Cohort Registry Study
  • Ketamine <1mg/kg vs >1mg/kg and Etomidate <0.3mg/kg vs >0.3mg/kg
  • ≈6800 patients: Etomidate ≈6,000pts and Ketamine ≈700pts
  • Primary Outcome: Peri-intubation hypotension in all intubations (SBP <100mmHg within 15min of intubation)
    • Ketamine = 18.3% and Etomidate = 12.4%
  • SBP <100mmHg within 15min of intubation in trauma patients
    • No difference between ketamine and etomidate
  • SBP <100mmHg within 15 min of intubation in dose reduced vs standard dose strategies
    • No difference
  • Groups were unbalanced:
    • More pts with sepsis in ketamine group
      • Ketamine 19.9% and Etomidate 10.9%
    • More pts with difficult airway characteristics in ketamine group
      • Ketamine 69.2% and Etomidate 60.4%
• Jabre et al. Lancet 2009. PMID: 19573904
  • Blinded Randomized Controlled Trial in France
  • 655 critically ill patients
  • Etomidate 0.3mg/kg vs 2mg/kg Ketamine
  • Pre and Post Intubation Blood Pressure
    • Etomidate: 5mmHg (-11 to 30)
    • Ketamine: 10mmHg (-10 to 33)
    • No statistical difference between groups

Bottom Line:

• Both NEAR trials were registry studies which do not allow for direct comparison of ketamine vs etomidate without randomization. Without randomization, the granular details of why a particular agent or dose of agent was chosen will lead to confounding factors that will give false conclusions
• Highest level evidence (Jabre et al) shows no difference in post-intubation hypotension rate (Ketamine = Etomidate)
• In “Big Sick” patients (Hemodynamically unstable), consider using reduced dose induction agents and a delayed sequence strategy to ensure patient is appropriately sedated before giving paralytics

Post Peer Reviewed By: Salim R. Rezaie, MD (Twitter: @srrezaie)

Cite this article as: Salim Rezaie, "Rebellion21: Ketamine vs Etomidate for RSI via Rob J. Bryant, MD", REBEL EM blog, September 22, 2021. Available at: https://rebelem.com/rebellion21-ketamine-vs-etomidate-for-rsi-via-rob-j-bryant-md/.